NO20026220L - Amider av R-2-(aminoaryl)-propionsyrer for anvendelse i forebyggingen av leukocyttaktivering - Google Patents
Amider av R-2-(aminoaryl)-propionsyrer for anvendelse i forebyggingen av leukocyttaktiveringInfo
- Publication number
- NO20026220L NO20026220L NO20026220A NO20026220A NO20026220L NO 20026220 L NO20026220 L NO 20026220L NO 20026220 A NO20026220 A NO 20026220A NO 20026220 A NO20026220 A NO 20026220A NO 20026220 L NO20026220 L NO 20026220L
- Authority
- NO
- Norway
- Prior art keywords
- amides
- aminoaryl
- prevention
- propionic acids
- leukocyte activation
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title abstract 2
- 210000000265 leukocyte Anatomy 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000004913 activation Effects 0.000 title 1
- 125000005001 aminoaryl group Chemical group 0.000 title 1
- 150000004672 propanoic acids Chemical class 0.000 title 1
- 235000019260 propionic acid Nutrition 0.000 title 1
- 210000003622 mature neutrocyte Anatomy 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- 206010018364 Glomerulonephritis Diseases 0.000 abstract 1
- 108090001007 Interleukin-8 Proteins 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010001053 acute respiratory failure Diseases 0.000 abstract 1
- 230000035605 chemotaxis Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004761 fibrosis Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000440 neutrophil Anatomy 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000007115 recruitment Effects 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 230000000451 tissue damage Effects 0.000 abstract 1
- 231100000827 tissue damage Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI000836A IT1318466B1 (it) | 2000-04-14 | 2000-04-14 | Ammidi di acidi r-2-(amminoaril)-propionici, utili nella prevenzionedell'attivazione leucocitaria. |
| PCT/EP2001/004137 WO2001079189A2 (en) | 2000-04-14 | 2001-04-11 | 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation' |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20026220D0 NO20026220D0 (no) | 2002-12-23 |
| NO20026220L true NO20026220L (no) | 2002-12-23 |
| NO325650B1 NO325650B1 (no) | 2008-06-30 |
Family
ID=11444862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20026220A NO325650B1 (no) | 2000-04-14 | 2002-12-23 | Amider av R-2-(aminoaryl)-propionsyrer for anvendelse i forebyggingen av leukocyttaktivering |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7217707B2 (no) |
| EP (1) | EP1276732B1 (no) |
| AT (1) | ATE374193T1 (no) |
| AU (2) | AU2001246539B2 (no) |
| CA (1) | CA2420585C (no) |
| CY (1) | CY1107078T1 (no) |
| CZ (1) | CZ303407B6 (no) |
| DE (1) | DE60130644T2 (no) |
| DK (1) | DK1276732T3 (no) |
| ES (1) | ES2292574T3 (no) |
| IT (1) | IT1318466B1 (no) |
| NO (1) | NO325650B1 (no) |
| PT (1) | PT1276732E (no) |
| RU (1) | RU2268263C2 (no) |
| WO (1) | WO2001079189A2 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20010395A1 (it) | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
| JP3801559B2 (ja) | 2002-12-26 | 2006-07-26 | ソニー株式会社 | 通信装置および方法、記録媒体、並びにプログラム |
| EP1457485A1 (en) | 2003-03-14 | 2004-09-15 | Dompé S.P.A. | Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| SI1579859T1 (sl) * | 2004-03-25 | 2007-04-30 | Dompe Pha R Ma Spa Res & Mfg | Uporaba n-(2-aril-propionil)-sulfonamidov za zdravljenje poskodbe hrbtnega mozga |
| EP1739078A1 (de) | 2005-05-30 | 2007-01-03 | Jerini AG | C5a-Rezeptor-Antagonisten |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH526538A (de) * | 1967-07-22 | 1972-08-15 | Merck Patent Gmbh | Verfahren zur Herstellung von Aminophenylessigsäure-Derivaten |
| SU436049A1 (no) * | 1971-01-25 | 1974-07-15 | Е. М. хман , Л. Б. Гвадыбадзе | |
| IT1193955B (it) * | 1980-07-22 | 1988-08-31 | Real Di Alberto Reiner S A S | Derivati ammidici dell'acido p-isobutilfenilpropionico, procedimento per la loro preparazione e relative composizioni farmaceutici |
| IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| IT1303685B1 (it) * | 1998-10-30 | 2001-02-23 | Dompe Spa | Procedimento per la preparazione di acidi alfa-arilalcanoici |
| IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
-
2000
- 2000-04-14 IT IT2000MI000836A patent/IT1318466B1/it active
-
2001
- 2001-04-11 DE DE60130644T patent/DE60130644T2/de not_active Expired - Lifetime
- 2001-04-11 WO PCT/EP2001/004137 patent/WO2001079189A2/en not_active Ceased
- 2001-04-11 RU RU2002130499/04A patent/RU2268263C2/ru not_active IP Right Cessation
- 2001-04-11 US US10/258,959 patent/US7217707B2/en not_active Expired - Lifetime
- 2001-04-11 EP EP01919448A patent/EP1276732B1/en not_active Expired - Lifetime
- 2001-04-11 ES ES01919448T patent/ES2292574T3/es not_active Expired - Lifetime
- 2001-04-11 DK DK01919448T patent/DK1276732T3/da active
- 2001-04-11 CZ CZ20023773A patent/CZ303407B6/cs not_active IP Right Cessation
- 2001-04-11 PT PT01919448T patent/PT1276732E/pt unknown
- 2001-04-11 AT AT01919448T patent/ATE374193T1/de active
- 2001-04-11 AU AU2001246539A patent/AU2001246539B2/en not_active Ceased
- 2001-04-11 AU AU4653901A patent/AU4653901A/xx active Pending
- 2001-04-11 CA CA002420585A patent/CA2420585C/en not_active Expired - Fee Related
-
2002
- 2002-12-23 NO NO20026220A patent/NO325650B1/no not_active IP Right Cessation
-
2007
- 2007-12-10 CY CY20071101566T patent/CY1107078T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7217707B2 (en) | 2007-05-15 |
| NO325650B1 (no) | 2008-06-30 |
| AU2001246539B2 (en) | 2005-06-02 |
| NO20026220D0 (no) | 2002-12-23 |
| CA2420585A1 (en) | 2001-10-25 |
| PT1276732E (pt) | 2007-12-06 |
| DE60130644D1 (de) | 2007-11-08 |
| DE60130644T2 (de) | 2008-08-14 |
| RU2268263C2 (ru) | 2006-01-20 |
| ITMI20000836A0 (it) | 2000-04-14 |
| US20040186146A1 (en) | 2004-09-23 |
| HK1051035A1 (en) | 2003-07-18 |
| CZ20023773A3 (cs) | 2003-03-12 |
| WO2001079189A3 (en) | 2003-10-09 |
| CA2420585C (en) | 2009-11-03 |
| AU4653901A (en) | 2001-10-30 |
| WO2001079189A2 (en) | 2001-10-25 |
| EP1276732B1 (en) | 2007-09-26 |
| ES2292574T3 (es) | 2008-03-16 |
| DK1276732T3 (da) | 2008-02-25 |
| EP1276732A1 (en) | 2003-01-22 |
| CZ303407B6 (cs) | 2012-09-05 |
| ATE374193T1 (de) | 2007-10-15 |
| CY1107078T1 (el) | 2012-10-24 |
| ITMI20000836A1 (it) | 2001-10-14 |
| IT1318466B1 (it) | 2003-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200200441A (et) | 2-arüülpropioonhappe amiidide R-enantiomeerid, nende valmistamismeetod, farmatseutiline kompositsioon ja 2-arüülpropioonhapete R-enantiomeerid | |
| MXPA03006786A (es) | Omega-aminoalquilamidas de los acidos r-2-aril-propionicos como inhibidores de la quimiotaxis de las celulas mononucleadas y polimorfonucleadas. | |
| AU753402B2 (en) | New substituted amides, their production and their use | |
| EP0468231B1 (de) | Guanidine | |
| CA2347752A1 (en) | N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them | |
| ATE293617T1 (de) | Oxybenzamidderivate als faktor-xa-inhibitoren | |
| RU2004122481A (ru) | Производные альфа-(n-сульфонамидо)ацетамида как ингибиторы бета-амилоида | |
| NO20045137L (no) | Diketohydrazinderivatforbindelser og legemidler inneholdende forbindelser som aktiv ingrediens | |
| MXPA04000278A (es) | Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales. | |
| ATE168007T1 (de) | Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole | |
| WO2001074791A1 (en) | Diazepane derivatives or salts thereof | |
| CY1107849T1 (el) | Η χρηση παραγωγων φουμαρικου οξεος για θεραπεια καρδιακης ανεπαρκειας και ασθματος | |
| GR3032220T3 (en) | Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation | |
| EP1208092A4 (en) | SULPHONAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS | |
| CY1107078T1 (el) | Αμιδια του r-2-(αμινοαρυλ)-προπιονικου οξεος για χρηση στην προληψη της ενεργοποιησης των λευκοκυτταρων | |
| JP2001502348A (ja) | 金属タンパク質分解酵素阻害剤 | |
| AR027754A1 (es) | Nuevo procedimiento para la sintesis de esteres de n-[(s)-1-carboxibutil]-(s)-alanina y aplicacion en la sintesis de perindopril | |
| NO20053726L (no) | Forbindelser med prolyloligopeptidase-hemmende aktivitet | |
| HRP20050815A2 (en) | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound | |
| JPH08119922A (ja) | ｏ−ピバロイル−チロシン誘導体 | |
| HK1037189A (en) | New heterocyclically substituted amides, their production and their use | |
| RU2003114437A (ru) | Новые производные цианоарил (или цианогетероарил-карбонилпиперазинил-пиримидинов, их получения и применение в качестве лекарственного средства | |
| BR0012554A (pt) | Derivado de 1,4,5,6-tetraidropirimidina como um inibidor da vitronectina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Reestablishment of rights (par. 72 patents act) | ||
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: DOMPE FARMACEUTICI S.P.A., IT |
|
| MM1K | Lapsed by not paying the annual fees |